Press "Enter" to skip to content

Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil

This partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libbs, which began in 2017 to launch biosimilar Trastuzumab in Brazil.

Original source: https://health.economictimes.indiatimes.com/news/pharma/81745520?utm_source=RSS&utm_medium=ETRSS

Also Read:   Bharat Biotech starts human trial of its anti-Covid vaccine at PGI Rohtak: Minister Anil Vij